A report by Novotech has identified emerging trends in the vaccine clinical trial sector, highlighting a shift towards adaptive trial designs. Published last week, the whitepaper reported that ...
Sarah Anderson, oncology strategy lead director, Novotech, discusses the growing prominence of triple-negative breast cancer clinical trials in the Asia-Pacific region, and the significant investments ...
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and ...
SYDNEY--(BUSINESS WIRE)--Novotech, the leading global full-service clinical Contract Research Organization (CRO), has released a comprehensive report analyzing the global clinical trial and drug ...
Sarah Anderson, oncology strategy lead director, Novotech, discusses the significance of triple-negative breast cancer ...
While we’ve had our eyes glued to TPG Capital’s exit attempts at the $4 billion Novotech, a small clinical trials deal has bobbed up to the surface, thanks to a cross-border M&A bet by Blackstone.